267 results on '"Silano M"'
Search Results
2. OC.15.2 SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
3. PC.01.9 HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE
4. T.05.10 CLINICAL HETEROGENEITY OF ADULT COELIAC DISEASE ACCORDING TO THE AGE AT ONSET: AN ITALIAN MULTICENTRIC STUDY
5. Junk food concept: seconds out
6. Policy implementation and priorities to create healthy food environments using the Healthy Food Environment Policy Index (Food-EPI): A pooled level analysis across eleven European countries
7. P301 Non-familial small bowel carcinomas in Crohnʼs disease: clinico-pathological, molecular and prognostic features
8. Implementation level of best practice policies by Italian Government for healthier food environments: Healthy Food Environment Policy Index (Food-EPI)
9. POS1192 BEHAVIOR AND FEELINGS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING LOCKDOWN MEASURES FOR THE COVID-19 OUTBREAK
10. Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis
11. Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0)
12. Role of extracellular microvesicles in celiac disease as potential pathogenetic agents and biomarkers of intestinal inflammation
13. Improved detection of colorectal neoplasms with selective use of chromoendoscopy in 2005 consecutive patients
14. CHARACTERIZATION OF OATS SAFETY IN CELIAC DISEASE IN RELATION TO THE CULTIVAR: O127
15. Agglutinating activity of alcohol-soluble proteins from quinoa seed flour in celiac disease
16. OC.06.1 ROLE OF EXTRACELLULAR MICROVESICLES IN CELIAC DISEASE AS POTENTIAL PATHOGENETIC AGENTS AND BIOMARKERS OF INTESTINAL INFLAMMATION
17. Implementation level of best practice policies by Italian government for healthier food environments
18. Clinical features of chronic C virus hepatitis in patients with celiac disease
19. Nuclear fluorescence serum reactivity on monkey oesophagus: a new antibody for the follow-up of coeliac disease?
20. Small bowel malignancy at diagnosis of coeliac disease
21. Anthropometric indicators of human immunodeficiency virus infection in infants with early and late symptoms in the first months of life
22. Growth patterns of breast fed and formula fed infants in the first 12 months of life: an Italian study
23. Programmed Cell Death Ligand-1 (PD-L1) Expression is Coupled with Microsatellite Instability in Non-Familial Small Bowel Carcinomas Associated or not with Coeliac Disease or Crohn's Disease: Results from the Small Bowel Cancer Italian Consortium
24. Unintended allergens in prepacked foods with and without precautionary allergen labelling: preliminary data relative to some recalled food types
25. Role of socio-economic status in observational studies: A study model on non-alcoholic steato-hepatitis (NASH)
26. Small bowel carcinomas in celiac or Crohn's disease: Distinctive histophenotypic, molecular and histogenetic patterns
27. Induction of apoptosis in Caco-2 cells by wheat gliadin peptides
28. OC.11.1 PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) EXPRESSION IS COUPLED WITH MICROSATELLITE INSTABILITY IN NON-FAMILIAL SMALL BOWEL CARCINOMAS ASSOCIATED OR NOT WITH COELIAC DISEASE OR CROHN'S DISEASE: RESULTS FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
29. Erratum
30. OC.10.4: Survival of Non-Familial Small Bowel Carcinomas Depends on the Underlying Intestinal Immune-Mediated Disorder
31. The Modern treatment of early gastric cancer: our experience an an Italian cohort
32. Degradazione del glutine mediante l’utilizzo di batteri lattici e proteasi fungine: nuove prospettive per la celiachia
33. Degradazione del glutine mediante l’utilizzo di batteri lattici e proteasi fungine: nuove prospettive per la celiachia. II Congresso nazionale
34. Degradazione del glutine mediante l’utilizzo di batteri lattici e proteasi fungine: nuove prospettive per la celiachia
35. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease
36. Delayed diagnosis of coealiac disease increases cancer risk
37. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue
38. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis
39. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis
40. 31-43 AMINOACIDIC SEQUENCE OF THE ALPHA-GLIADIN INDUCES ANTIENDOMYSIAL ANTIBODY PRODUCTION DURING IN VITRO CHALLENGE
41. Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro
42. ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES FROM CELIAC PATIENTS ARE RESPONSIBLE OF TROPHOBLAST DAMAGE VIA APOPTOSIS IN VITRO: A POSSIBLE ROLE FOR INFERTILITY, EARLY PREGNANCY LOSS AND INTRAUTERINE GROWTH RETARDATION?
43. A decapeptide from durum wheat promotes a shift from Th1 towards Th2 type of pathogenic immune response in coeliac disease
44. A DECAPEPTIDE FROM DURUM WHEAT PREVENTS GLIADIN PEPTIDES‐INDUCED APOPTOSIS IN COELIAC SMALL BOWEL MUCOSA
45. A DECAPEPTIDE FROM DURUM WHEAT PREVENTS COELIAC PERIPHERAL BLOOD LYMPHOCYTES FROM ACTIVATION BY GLIADIN PEPTIDES
46. SYNERGIC TOXIC EFFECT OF P31‐43 AND IL‐15 ON A HUMAN INTESTINAL EPITHELIAL CELL LINE
47. CORRELATION BETWEEN TISSUE TRANSGLUTAMINASE EXPRESSION AND DEGREE OF TISSUE DAMAGE IN COELIAC SMALL INTESTINAL MUCOSA
48. Protective effects of mannan in Caco-2/TC7 cells treated with wheat-derived peptides
49. A CELL SURFACE TISSUE TRANSGLUTAMINASE IS INVOLVED IN RECOGNITION OF GLIADIN PEPTIDES BY K 562 CELLS
50. MANNAN PREVENTS GLIADIN PEPTIDES TOXICITY ON CACO-2 CELLS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.